WING FUNG GROUP (08526) announced its interim performance, reporting a net loss of HKD 9.522 million, a year-on-year increase of 256.9%.
Rongfeng Group Asia (08526) announced its interim results for the six months ending June 30, 2026, with revenue of HK$131 million, a year-on-year increase of 97.08%; during the period, it recorded a loss of HK$9.522 million, a year-on-year increase of 256.9%; basic loss per share was HK$0.0587.
WING FUNG GROUP (08526) announced its interim results for the six months ended June 30, 2026, with revenue of HK$131 million, an increase of 97.08% year-on-year; for the period, the loss was HK$9.522 million, an increase of 256.9% year-on-year; the basic loss per share was HK$0.0587.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





